Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ipochem is a Polish research and development company specializing in the synthesis of complex organic compounds and active pharmaceutical ingredients (APIs). Founded in 1992 and based in Warsaw, the company provides custom synthesis, process development, and contract manufacturing services to the global pharmaceutical and biotech industries. Their expertise includes the production of high-potency APIs, generic drug substances, and intermediates for clinical trials. Ipochem operates state-of-the-art laboratories and pilot-scale facilities to support drug development from initial research through to commercial production. The company is recognized for its ability to handle challenging multi-step chemical syntheses and provide comprehensive analytical support. By offering both R&D and small-scale manufacturing, Ipochem serves as a strategic partner for companies looking to outsource chemical process optimization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ipochem.